BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  Alcon Announces Results of 2026 Annual General Meeting

  May 1, 2026

   · 

  2 min read
• Press Releases

  Aptar Reports First Quarter 2026 Results

  May 1, 2026

   · 

  19 min read
• Press Releases

  FibroBiologics Reports Q1 2026 Financial Results and Provides Corporate Update

  May 1, 2026

   · 

  7 min read
• Press Releases

  TLX101-Px (Pixlumi®) MAA Accepted in Europe

  May 1, 2026

   · 

  9 min read
• Press Releases

  Totus Medicines to Present Interim Phase 1b Clinical Data for TOS-358 + Fulvestrant Doublet Therapy in HR+/HER- Breast Cancer Patients at ESMO Breast Cancer Annual Congress 2026

  May 1, 2026

   · 

  2 min read
• Press Releases

  YD Bio Limited Reports Full Year 2025 Financial Results

  May 1, 2026

   · 

  12 min read
• Press Releases

  Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering

  May 1, 2026

   · 

  4 min read
• Press Releases

  /C O R R E C T I O N -- Amgen/

  May 1, 2026

   · 

  44 min read
• 

  FDA

  FDA taps Szarama as acting CBER director as Prasad’s tumultuous tenure ends

  Katherine Szarama, who has served as Prasad’s deputy at the Center for Biologics Evaluation and Research since December, joins a long list of temporary leaders at the Department of Health and Human Services.

  May 1, 2026

   · 

  2 min read

   · 

  Heather McKenzie
• Press Releases

  Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock

  May 1, 2026

   · 

  4 min read